HOLX vs PMCB · P/E 32, rev $4.10B vs $8.6M cap
Hologic Inc (HOLX) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the HOLX and PMCB stock pages for the full models.
Not investment advice.